Patient Education Guide: ZYTIGA (Abiraterone Acetate) 250mg
ZYTIGA (Abiraterone Acetate) is a specialized hormone therapy used to treat men with metastatic castration-resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer (mCSPC). Unlike traditional chemotherapy, Zytiga is an androgen biosynthesis inhibitor. It works by blocking the enzyme CYP17, which prevents the body from producing testosterone in three places: the testes, the adrenal […]
Patient Education Guide: ZYTIGA (Abiraterone Acetate) 250mg Read More »
